215 related articles for article (PubMed ID: 38504159)
21. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
Ying Y; Li J; Xie H; Yan H; Jin K; He L; Ma X; Wu J; Xu X; Fang J; Wang X; Zheng X; Liu B; Xie L
Cell Prolif; 2020 Feb; 53(2):e12751. PubMed ID: 31971654
[TBL] [Abstract][Full Text] [Related]
22. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
[TBL] [Abstract][Full Text] [Related]
23. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p.
Zheng M; Xu L; Wei C; Guan W
Hormones (Athens); 2023 Jun; 22(2):281-293. PubMed ID: 36826778
[TBL] [Abstract][Full Text] [Related]
24. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
25. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
[TBL] [Abstract][Full Text] [Related]
26. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract][Full Text] [Related]
27. miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.
Lv G; Wu M; Wang M; Jiang X; Du J; Zhang K; Li D; Ma N; Peng Y; Wang L; Zhou L; Zhao W; Jiao Y; Gao X; Hu Z
Liver Int; 2017 Sep; 37(9):1354-1364. PubMed ID: 28317284
[TBL] [Abstract][Full Text] [Related]
28. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
30. IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
Zhang X; Shi L; Sun HD; Wang ZW; Xu F; Wei JF; Ding Q
Clin Transl Med; 2023 Sep; 13(9):e1427. PubMed ID: 37743642
[TBL] [Abstract][Full Text] [Related]
31. MiR-133b regulates the proliferation, colony formation, and invasion of bladder cancer cells via inhibiting SOX4.
Zhong M; Jiang F; Song L; Nie M; Lan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):407-415. PubMed ID: 35545336
[TBL] [Abstract][Full Text] [Related]
32. LINC00460 facilitated tongue squamous cell carcinoma progression via the miR-320b/IGF2BP3 axis.
Wu K; Wang X; Yu H; Yu Z; Wang D; Xu X
Oral Dis; 2022 Sep; 28(6):1496-1508. PubMed ID: 33660359
[TBL] [Abstract][Full Text] [Related]
33. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis.
Tan J; Liu B; Zhou L; Gao J; Wang XK; Liu Y; Wang JR
Cell Signal; 2022 Mar; 91():110216. PubMed ID: 34920123
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Zhang G; He X; Ren C; Lin J; Wang Q
J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
[TBL] [Abstract][Full Text] [Related]
35. MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.
Feng J; Guo J; Wang JP; Chai BF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3665-3673. PubMed ID: 32329842
[TBL] [Abstract][Full Text] [Related]
36. Silencing long noncoding RNA LINC01133 suppresses pancreatic cancer through regulation of microRNA-1299-dependent IGF2BP3.
Li S; Jiang F; Chen F; Deng Y; Huang H
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23534. PubMed ID: 37718503
[TBL] [Abstract][Full Text] [Related]
37. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
38. Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis.
Kang W; Wang Q; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Jin X; Cui Z
Cell Death Dis; 2020 Dec; 11(12):1038. PubMed ID: 33288752
[TBL] [Abstract][Full Text] [Related]
39. Isoliquiritigenin inhibits non-small cell lung cancer progression via m
Cui Y; Wu Y; Wang C; Wang Z; Li Y; Jiang Z; Zhao W; Pan Z
Phytomedicine; 2022 Sep; 104():154299. PubMed ID: 35816995
[TBL] [Abstract][Full Text] [Related]
40. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]